Errata Corrige, Thalassemia Reports 2017; 7:6392
Referring to the article: Baiamonte E, Barone R, Contino F, et al. Granulocytecolony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile, published on Thalassemia Reports 2017; vo...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | Thalassemia Reports |
Online Access: | http://www.pagepressjournals.org/index.php/thal/article/view/7024 |
_version_ | 1797966817715552256 |
---|---|
author | Editorial Office |
author_facet | Editorial Office |
author_sort | Editorial Office |
collection | DOAJ |
description | Referring to the article: Baiamonte E, Barone R, Contino F, et al. Granulocytecolony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile, published on Thalassemia Reports 2017; volume 7:6392, the following sentence in the Materials and Mehods section is not correct:
(Filgrastim, Amgen, Thousand Oaks, CA, USA).
Corrected sentence must be intended as follows:
[Myelostim 34 F 33,6 33,6 MUI (263 mcg) (Lenograstim), Italfarmaco S.P.A.] |
first_indexed | 2024-04-11T02:21:20Z |
format | Article |
id | doaj.art-3a166adc2584464bbcd1bb42918a4128 |
institution | Directory Open Access Journal |
issn | 2039-4357 2039-4365 |
language | English |
last_indexed | 2024-04-11T02:21:20Z |
publishDate | 2017-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Thalassemia Reports |
spelling | doaj.art-3a166adc2584464bbcd1bb42918a41282023-01-02T23:41:01ZengMDPI AGThalassemia Reports2039-43572039-43652017-08-017110.4081/thal.2017.70245375Errata Corrige, Thalassemia Reports 2017; 7:6392Editorial Office0Thalassemia Reports, PAGEPressReferring to the article: Baiamonte E, Barone R, Contino F, et al. Granulocytecolony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile, published on Thalassemia Reports 2017; volume 7:6392, the following sentence in the Materials and Mehods section is not correct: (Filgrastim, Amgen, Thousand Oaks, CA, USA). Corrected sentence must be intended as follows: [Myelostim 34 F 33,6 33,6 MUI (263 mcg) (Lenograstim), Italfarmaco S.P.A.]http://www.pagepressjournals.org/index.php/thal/article/view/7024 |
spellingShingle | Editorial Office Errata Corrige, Thalassemia Reports 2017; 7:6392 Thalassemia Reports |
title | Errata Corrige, Thalassemia Reports 2017; 7:6392 |
title_full | Errata Corrige, Thalassemia Reports 2017; 7:6392 |
title_fullStr | Errata Corrige, Thalassemia Reports 2017; 7:6392 |
title_full_unstemmed | Errata Corrige, Thalassemia Reports 2017; 7:6392 |
title_short | Errata Corrige, Thalassemia Reports 2017; 7:6392 |
title_sort | errata corrige thalassemia reports 2017 7 6392 |
url | http://www.pagepressjournals.org/index.php/thal/article/view/7024 |
work_keys_str_mv | AT editorialoffice erratacorrigethalassemiareports201776392 |